Author Posts Archive: Marcy Darnovsky, PhD
Many genetic, reproductive, and biomedical technologies now in development pose new societal challenges, raising questions about how we understand and uphold social justice, human rights, and even our shared humanity.
Drawing lessons from other countries’ regulatory successes could help temper the commercial pressures in the U.S. assisted reproduction sector, without in any way diminishing reproductive rights.
In the wake of the Bush administration’s policies, we will have the political space to craft a pro-research stand that simultaneously highlights the need for consistent and enforceable regulation, for hope without hype, and for developing human biotechnologies according to principles of social justice and human rights.